Cochlear

Cochlear OCF Growth YoY

The Year-over-Year Operating Cash Flow Growth of Cochlear (COH.AX) as of Nov 3, 2026 is 54.88 %. In the previous year, Year-over-Year Operating Cash Flow Growth was -38.89 % — a change of -241.13% (higher).

OCF Growth YoY

54.88 %

YoY

-241.13%

Last updated:

Year-over-Year Operating Cash Flow Growth of Cochlear is 2026 54.88 % . Year-over-Year Operating Cash Flow Growth of Cochlear was 2025 -38.89 % . It decreases by -241.13% higher compared to the previous year.

The Cochlear OCF Growth YoY history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF Growth YoY
Date
OCF Growth YoY
Jan 1, 2019
14.68 AUD
Jan 1, 2020
-153.31 AUD
Jan 1, 2021
268.19 AUD
Jan 1, 2022
41.86 AUD
Jan 1, 2023
-3.75 AUD
Jan 1, 2024
7.28 AUD
Jan 1, 2025
-38.89 AUD
Jan 1, 2026
54.88 AUD
The Cochlear OCF Growth YoY history
YEAROCF Growth YoYYoY
54.88 %-241.13%
-38.89 %-633.84%
7.28 %-294.52%
-3.75 %-108.95%
41.86 %-84.39%
268.19 %-274.93%
-153.31 %-1,144.05%
14.68 %-2,344.10%
-0.65 %-101.62%
40.35 %-2,221.92%
-1.90 %-102.74%
69.36 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cochlear Stock analysis

What does Cochlear do? Cochlear Ltd is an Australian-based medical technology company founded in 1981 by engineer Professor Graeme Clark. The company specializes in Cochlear implant systems and other hearing devices. Cochlear Ltd offers accessories, services, and rehabilitation training for individuals with hearing impairments. The company's products are available for both children and adults with varying degrees of hearing loss. Cochlear Ltd operates in different sectors, including Cochlear implant systems, hearing aids, and wireless accessories and streaming systems under the brand names Nucleus® and Baha®. Nucleus® systems utilize a fully implantable cochlear implant and external speech processor to convert sound into electrical signals for interpretation by the brain. Baha® systems are bone-anchored hearing devices for individuals with unilateral to moderate hearing impairments. Cochlear Ltd also provides wireless accessories and streaming systems to connect devices like mobile phones, TVs, and music players to the hearing aids and cochlear implants, improving hearing performance and enhancing social lives. The company has a strong global presence, operating in over 100 countries with headquarters in Australia, multiple production facilities, and research centers. Cochlear Ltd has received numerous awards and recognition for its products and services and is committed to researching and developing new therapies and technologies to improve the lives of individuals with hearing impairments. Cochlear is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cochlear stock

Year-over-Year Operating Cash Flow Growth of Cochlear is 54.88 % in 2026.

On Eulerpool you can find the complete historical development of Year-over-Year Operating Cash Flow Growth Cochlear since 2006 – with annual values, charts, and detailed analysis.

OCF growth measures the percentage change in operating cash flow. Growing OCF indicates improving cash generation from core operations.

To evaluate Year-over-Year Operating Cash Flow Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Operating Cash Flow Growth.

Year-over-Year Operating Cash Flow Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Operating Cash Flow Growth's Cochlear historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Cochlear

All Key Metrics — Cochlear